Peña VR, Cruz TG, Castillo RA, Sorcia RM, Huerta RJF

Language: Spanish
References: 23
Page: 555-559
PDF size: 201.59 Kb.

ABSTRACT

Background: SARS-CoV-2 infection is observed more frequently in children, with an apparently milder course compared to adults.
Objective: To present the clinical characteristics and evolution of children diagnosed with COVID-19 treated in a first-level care unit.
Material and Methods: Information was obtained from the records of children treated for respiratory and digestive symptoms, in whom a diagnosis of COVID-19 was made by antigen test, during the month of September 2021.
Results: 75 children out of 220 samples were positive for COVID-19. All children presented mild symptoms, the most frequent were fever, headache, and cough. At diagnosis, 60% of the children were overweight or obese but had no other comorbidities. At a two-week follow-up, no patient required hospitalization or presented any complication.
Conclusion: In children with COVID-19, the course of the infection can have a favorable evolution, mainly when there are no comorbidities.

REFERENCES

1. Howard-Jones AR, Bowen AC, Danchin M, Koirala A, SharmaK, Yeoh DK, et al. COVID-19 in children: I. Epidemiology,prevention and indirect impacts. J Paediatr Child Health. 2022;58(1):39–45.

2. Peña-Vélez R, Cruz-Taboada G, Castillo-Rodríguez A, SorciaRamírez M, Huerta-Romano JF. Covid-19 after school opening in a population of students in Mexico. Salud PublicaMex. 2022;64(2):230-231.

3. del Campo-Martínez M de los Á, Sánchez-Jara B, LópezSantiago NC, Lozano-Garcidueñas M, Soto-Padilla JM,Moreno-González AM, et al. COVID-19 en el pacientepediátrico. Gac Med Mex.2021;157(Supl3):S120-S130

4. Martínez-García JJ, Luna-Méndez JE, Alarid-Coronel D,Lares-Payan A, Picasso-López DE, León-Sicairos NM, et al.Clinical and epidemiological characteristics of COVID-19 inchildren: Experience in two hospitals. Bol Med Hosp InfantMex. 2021;78(6):506-14.

5. Raiden S, Cairoli H, Potasnik J, Di Lalla S, Chiolo MJ, TorresF, et al. Children hospitalized for COVID-19 during the firstwinter of the pandemic in Buenos Aires, Argentina. BolMed Hosp Infant Mex. 2021;78(6):501–5.

6. Tuta-Quintero E, Martínez-Ayala C, Mantilla-Beltrán G,Rueda-Rodríguez A, Pimentel J. Multisystem inflammatorysyndrome and COVID-19: a scoping review. Bol Med HospInfant Mex. 2022;79(2):69-82.

7. Rivas-Ruiz R, Roy-García IA, Ureña-Wong KR, Aguilar-ItuarteF, Vázquez-De Anda GF, Gutiérrez-Castrellón P, et al. Mortality risk factors in mexican children with covid-19. GacMed Mex. 2020;156(6):526–32.

8. Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, TamezTorres KM, Román-Montes CM, Díaz-Mejía BA, et al. Clinicaland epidemiological characteristics of patients diagnosed withcovid-19 in a tertiary care center in mexico city: a prospectivecohort study. Rev Invest Clin. 2020;72(3):165–77.

9. Viner RM, Ward JL, Hudson LD, Ashe M, Patel SV, Hargreaves D, et al. Systematic review of reviews of symptomsand signs of COVID-19 in children and adolescents. ArchDis Child. 2020;106(8):802–7.

10. Gallardo-Alfaro L, Lorente-Montalvo P, Cañellas M, Carandell E, Oliver A, Rojo E, et al. Diagnostic accuracy ofPanbioTM rapid antigen test for SARS-CoV-2 in paediatricpopulation. BMC Pediatr. 2023;23(1).

11. González-Donapetry P, García-Clemente P, Bloise I, GarcíaSánchez C, Sánchez Castellano MÁ, Romero MP, et al.Think of the Children: Evaluation of SARS-CoV-2 RapidAntigen Test in Pediatric Population. Pediatr Infect Dis J.2021;40(5):385–8.

12. Márquez-González H, Miranda-Novales MG, SolórzanoSantos F, Klunder-Klunder M, Garduño-Espinoza J, MéndezGalván JF. Covid-19 pandemic: Challenges ahead. Bol MedHosp Infant Mex. 2020;77(5):242–51.

13. Wong-Chew RM, Noyola DE, Villa AR. Características clínicas y factores de riesgo de mortalidad en menores de18 años con COVID-19 en México y Ciudad de México. AnPediatr (Barc). 2022;97(2):119-128.

14. Márquez-Aguirre MP, Gutiérrez-Hernández A, LizárragaLópez SL, Muñoz-Ramírez CM, Ventura-Gómez ST, delSocorro Zárate-Castañón PM, et al. Clinical spectrumof COVID-19 in the pediatric patient. Acta Pediatr Mex.2020;41(4):S64–71.

15. Mansourian M, Ghandi Y, Habibi D, Mehrabi S. COVID-19infection in children: A systematic review and meta-analysisof clinical features and laboratory findings. Arch Pediatr.2021;28(3):242–8.

16. Akobeng AK, Grafton-Clarke C, Abdelgadir I, Twum-BarimahE, Gordon M. Gastrointestinal manifestations of COVID-19in children: a systematic review and meta-analysis. Frontline Gastroenterol. 2021;12(4):332–7.

17. Carballal-Mariño M, Balaguer-Martínez JV, García-Vera C,Morillo-Gutierrez B, Domínguez-Aurrecoechea B, JimenezAlés R, et al. Expresión clínica de la COVID-19 en pediatríade atención primaria: estudio COVIDPAP. An Pediatría.2022;97(1):48–58.

18. Calvo C, García López-Hortelano M, de Carlos Vicente JC,Vázquez Martínez JL, Ramos JT, Baquero-Artigao F, et al.Recomendaciones sobre el manejo clínico de la infecciónpor el «nuevo coronavirus» SARS-CoV2. Grupo de trabajode la Asociación Española de Pediatría (AEP). An Pediatría.2020;92(4):241.

19. Venturini E, Montagnani C, Garazzino S, Donà D, PierantoniL, Vecchio A Lo, et al. Treatment of children with COVID-19:update of the Italian Society of Pediatric Infectious Diseasesposition paper. Ital J Pediatr. 2021;47(1):1–4.

20. Tripathi S, Christison AL, Levy E, McGravery J, Tekin A, Bolliger D, et al. The Impact of Obesity on Disease Severity andOutcomes Among Hospitalized Children With COVID-19.Hosp Pediatr. 2021;11(11):e297–316.

21. Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour J,et al. Risk Factors for Severe COVID-19 in Children. PediatrInfect Dis J. 2021;E137–45.

22. Moreira A, Chorath K, Rajasekaran K, Burmeister F, AhmedM, Moreira A. Demographic predictors of hospitalizationand mortality in US children with COVID-19. Eur J Pediatr.2021;180(5):1659.

23. Toba N, Gupta S, Ali AY, ElSaban M, Khamis AH, Ho SB, etal. COVID‐19 under 19: A meta‐analysis. Pediatr Pulmonol.2021;56(6):1332.